Thrombosis | CHOP Research Institute
 

Thrombosis

Dr. Rauova is a researcher in the Division of Hematology at CHOP and a research associate professor of Pediatrics in the Perelman School of Medicine at the University of Pennsylvania. Her research focuses on the molecular and cellular interactions involved in hemostasis and thrombosis.

E-mail:
lubica [at] chop.edu

The Camire Lab is interested in understanding the components of the blood coagulation system, how they interface with activated cells, and how disturbances in their function lead to bleeding and thrombosis.

Dr. Raffini's clinical research includes evidence-based strategies to prevent thrombosis in hospitalized children, optimizing anticoagulation therapy to improve outcomes in children with thrombosis, and use of novel therapies in pediatric patients with bleeding disorders.

E-mail:
raffini [at] chop.edu
Published on
Dec 18, 2019
Sriram Krishnaswamy, PhD, receives ASH’s 2019 prestigious Ernest Beutler Lecture award and gives talk at Society’s annual meeting in Florida.
Published on
Dec 21, 2018
“The problem with too much clotting is by far one of the most staggering medical issues in the Western world,” Dr. Krishnaswamy said. See what he and his colleagues are doing to combat this deadly disease.

Dr. Camire's research focuses on understanding the components of the blood coagulation system, how they interface with activated cells, and how disturbances in their function lead to bleeding and thrombosis. He is also interested in developing novel therapeutic approaches (protein, gene-based, small molecule) to mitigate these events, which are major causes of morbidity and mortality worldwide.

E-mail:
camire [at] chop.edu
Published on
Jun 3, 2015
The International Society on Thrombosis and Haemostasis will honor The Children’s Hospital of Philadelphia’s Sriram Krishnaswamy, PhD, at its annual meeting.
Published on
Nov 17, 2014
The Children’s Hospital of Philadelphia’s Sriram Krishnaswamy, PhD, is set to deliver this year’s Sol Sherry Distinguished Lecture in Thrombosis at this week’s American Heart Association Scientific Sessions annual conference.